Linagliptin / metformin Alternatives Compared
| Linagliptin / metformin | Ozempic (semaglutide) | Mounjaro (tirzepatide) |
|
|---|
| Linagliptin / metformin | Ozempic (semaglutide) | Mounjaro (tirzepatide) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Diabetes - Type 2. Linagliptin / metformin may also be used for purposes not listed in this medication guide. |
Prescription only
Ozempic lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the liver. It is... View more |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Diabetes - Type 2. Mounjaro may also be used for purposes not listed in this medication guide. |
Related suggestions Diabetes, Type 2
|
|||||||||||||||
| More about Linagliptin / metformin | More about Ozempic (semaglutide) | More about Mounjaro (tirzepatide) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Linagliptin / metformin has an average rating of 6.2 out of 10 from a total of 17 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 33% reported a negative effect. |
Ozempic has an average rating of 6.6 out of 10 from a total of 1364 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 24% reported a negative effect. |
Mounjaro has an average rating of 8.6 out of 10 from a total of 1078 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 7% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ozempic prices |
View all Mounjaro prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Jentadueto, Jentadueto XR | Other semaglutide brands include: Rybelsus, Wegovy | Other tirzepatide brands include: Zepbound | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
12 hours |
168 hours |
120 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 441 drugs are known to interact with Linagliptin / metformin:
|
A total of 266 drugs are known to interact with Ozempic:
|
A total of 411 drugs are known to interact with Mounjaro:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
||||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
January 30, 2012 |
N/A |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.